LON:VRP Verona Pharma Share Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Verona Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 62.50 0.00 (0.00 %) (As of 09/22/2020 12:00 AM ET) Add Compare Share Today's Range 61.75Now: GBX 62.50▼ 64.5050-Day Range 62.50MA: GBX 72.12▼ 82.5052-Week Range 0.66Now: GBX 62.50▼ 115Volume118,195 shsAverage Volume154,340 shsMarket Capitalization£259.09 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartHeadlinesOptions Chain Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.Read More Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:VRP Previous Symbol CUSIPN/A CIKN/A Webwww.veronapharma.com Phone+44-20-32834200Debt Debt-to-Equity Ratio6.85 Current Ratio2.99 Quick Ratio2.47Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 15.40 per share Price / Cash Flow4.06 Book ValueGBX 18 per share Price / Book3.47Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees22 Outstanding Shares414,545,984Market Cap£259.09 million Next Earnings DateN/A OptionableOptionable GBX 62.50 0.00 (0.00 %) (As of 09/22/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive VRP News and Ratings via Email Sign-up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter. Verona Pharma (LON:VRP) Frequently Asked Questions How has Verona Pharma's stock price been impacted by COVID-19? Verona Pharma's stock was trading at GBX 49 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VRP stock has increased by 27.6% and is now trading at GBX 62.50. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Verona Pharma? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verona Pharma in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Verona Pharma. How were Verona Pharma's earnings last quarter? Verona Pharma Plc (LON:VRP) announced its quarterly earnings results on Thursday, February, 27th. The company reported ($30.30) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($30.80) by $0.50. View Verona Pharma's earnings history. Who are some of Verona Pharma's key competitors? Some companies that are related to Verona Pharma include PureTech Health (PRTC), Aptose Biosciences (APS), Oxford BioMedica (OXB), SIGA Technologies (SIGA), CEL-SCI (CVM), Biotest (BIO), Altimmune (ALT), iShares Diversified Alternatives Trust (ALT), Pfenex (PFNX), Pfenex (PFNX), Inventiva (IVA), IMV (IMV), Ibio (IBIO), Ergomed (ERGO) and Silence Therapeutics (SLN). View all competitors. What other stocks do shareholders of Verona Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma investors own include VERONA PHARMA P/S (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), GRIFOLS S A/S (GRFS) and Innoviva (INVA). Who are Verona Pharma's key executives? Verona Pharma's management team includes the following people: Dr. Jan-Anders Karlsson, CEO & Exec. Director (Age 64)Mr. Piers John Morgan, Chief Financial Officer (Age 53)Ms. Claire Louise Poll L.C.S.W., B.A., B Juris, LLB, ASIA, Gen. Counsel (Age 52)Ms. Victoria Stewart, Director of CommunicationsDr. Peter Spargo, Sr. VP of Chemistry Manufacturing & Controls (Age 57) What is Verona Pharma's stock symbol? Verona Pharma trades on the London Stock Exchange (LON) under the ticker symbol "VRP." How do I buy shares of Verona Pharma? Shares of VRP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Verona Pharma's stock price today? One share of VRP stock can currently be purchased for approximately GBX 62.50. How big of a company is Verona Pharma? Verona Pharma has a market capitalization of £259.09 million. Verona Pharma employs 22 workers across the globe. What is Verona Pharma's official website? The official website for Verona Pharma is www.veronapharma.com. How can I contact Verona Pharma? Verona Pharma's mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The company can be reached via phone at +44-20-32834200. This page was last updated on 9/23/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
